Dynamics, fragility, and glass transition of low-molecular-weight linear homopolymers

被引:10
|
作者
Andreozzi, L. [1 ]
Autiero, C.
Faetti, M.
Giordano, M.
Zulli, F.
机构
[1] Univ Pisa, Dept Phys E Fermi, Pisa, Italy
[2] CNR, INFM, PolyLab, I-56100 Pisa, Italy
关键词
glass transition; polymers; fragility; molecular weight; free volume;
D O I
10.1080/14786430802468231
中图分类号
T [工业技术];
学科分类号
08 ;
摘要
Analysis of the dynamics of low-molar-mass linear homopolymers is important when trying to understand the mechanisms driving structural relaxation properties from molecular liquids to polymers. Theoretical models assume, in general, the same mobility of the different moieties of the macromolecule, but this hypothesis fails for low-molar-mass polymers. Therefore, isofrictional comparisons are necessary to interpret experimental data with theoretical models. In this work, the molar-mass dependence of the glass transition temperatures T(g), fragility indexes, and dynamic moduli of unentangled poly(ethyl acrylate) (PEA) melts are studied and discussed. All the results are interpreted in a coherent framework developed from the free-volume concept. The predictive power of this framework is also tested to fit theoretical and experimental master curves, introducing an 'inverse' isofrictional correction.
引用
收藏
页码:4151 / 4159
页数:9
相关论文
共 50 条
  • [41] PHARMACOKINETICS OF LOW-MOLECULAR-WEIGHT HEPARINS
    BARA, L
    SAMAMA, M
    ACTA CHIRURGICA SCANDINAVICA, 1990, : 57 - 61
  • [42] Low-molecular-weight heparin and outcomes
    Arbit, E
    CHEST, 2005, 128 (01) : 471 - 471
  • [43] HEPARIN AND LOW-MOLECULAR-WEIGHT HEPARINS
    HIRSH, J
    CORONARY ARTERY DISEASE, 1992, 3 (11) : 990 - 1002
  • [44] PHARMACOLOGY OF LOW-MOLECULAR-WEIGHT HYDROXYETHYLSTARCHES
    BARON, JF
    ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION, 1992, 11 (05): : 509 - 515
  • [45] LOW-MOLECULAR-WEIGHT RHEUMATOID FACTOR
    CHODIRKER, WB
    TOMASI, TB
    JOURNAL OF CLINICAL INVESTIGATION, 1963, 42 (06): : 876 - &
  • [46] LOW-MOLECULAR-WEIGHT HEPARIN TO BE MARKETED
    不详
    CLINICAL PHARMACY, 1993, 12 (07): : 471 - &
  • [47] Low-molecular-weight heparin and cancer
    Zacharski, LR
    Ornstein, DL
    Mamourian, AC
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2000, 26 : 69 - 77
  • [48] Low-molecular-weight heparin and thrombocytopenia
    Silver, D
    VASCULAR SURGERY, 1997, 31 (04): : 409 - 411
  • [49] Low-molecular-weight heparins and thrombocytosis
    Liautard, C
    Nunes, AMC
    Vial, T
    Chatillon, F
    Guy, C
    Ollagnier, M
    Descotes, J
    ANNALS OF PHARMACOTHERAPY, 2002, 36 (09) : 1351 - 1354
  • [50] A GUIDE TO LOW-MOLECULAR-WEIGHT GTPASES
    SANDERS, DA
    CELL GROWTH & DIFFERENTIATION, 1990, 1 (05): : 251 - 258